Total Payments
$967.00
2022 Payments
$91.91
Companies
14
Transactions
35
Medicare Patients
2,625
Medicare Billing
$321,478
Payment Breakdown by Category
Food & Beverage$967.00 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $967.00 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $286.38 | 5 | $0 (2021) |
| PFIZER INC. | $127.91 | 8 | $0 (2019) |
| Kaleo, Inc. | $107.06 | 1 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $91.91 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $90.16 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $63.12 | 4 | $0 (2019) |
| Amgen Inc. | $50.48 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $33.83 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $29.38 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $26.21 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $91.91 | 1 | Neurocrine Biosciences, Inc. ($91.91) |
| 2021 | $133.13 | 1 | E.R. Squibb & Sons, L.L.C. ($133.13) |
| 2020 | $42.88 | 2 | AstraZeneca Pharmaceuticals LP ($26.21) |
| 2019 | $313.17 | 14 | Kaleo, Inc. ($107.06) |
| 2018 | $369.93 | 16 | E.R. Squibb & Sons, L.L.C. ($141.14) |
| 2017 | $15.98 | 1 | Novartis Pharmaceuticals Corporation ($15.98) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $91.91 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $133.13 | General |
| Category: Cardiovascular | ||||||
| 02/13/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Respiratory | ||||||
| 10/31/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiology | ||||||
| 09/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiology | ||||||
| 05/02/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/25/2019 | Kaleo, Inc. | EVZIO (Drug) | Food and Beverage | In-kind items and services | $107.06 | General |
| Category: OPIOID ANTAGONIST | ||||||
| 04/18/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/17/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: Cardiovascular | ||||||
| 03/07/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/07/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiology | ||||||
| 12/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/29/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $112.90 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 565 | 947 | $157,265 | $70,999 |
| 2022 | 7 | 642 | 1,045 | $178,764 | $79,997 |
| 2021 | 9 | 766 | 1,106 | $193,482 | $89,414 |
| 2020 | 7 | 652 | 948 | $168,800 | $81,070 |
Total Patients
2,625
Total Services
4,046
Medicare Billing
$321,478
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 215 | 531 | $65,844 | $32,486 | 49.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 133 | 136 | $27,472 | $12,109 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 88 | 89 | $33,909 | $11,820 | 34.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 119 | $21,182 | $10,745 | 50.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 30 | $2,220 | $1,178 | 53.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 19 | $2,603 | $1,153 | 44.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,827 | $1,133 | 40.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 12 | 12 | $1,208 | $374.31 | 31.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 207 | 556 | $68,944 | $31,166 | 45.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 164 | 165 | $59,235 | $25,865 | 43.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 152 | 154 | $28,315 | $12,988 | 45.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 84 | $14,952 | $6,815 | 45.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 53 | $3,710 | $1,673 | 45.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 22 | 22 | $2,222 | $859.70 | 38.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $1,386 | $629.77 | 45.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 153 | 154 | $54,320 | $24,495 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 203 | 399 | $49,476 | $23,330 | 47.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 126 | 235 | $41,830 | $19,358 | 46.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 177 | 180 | $32,580 | $15,283 | 46.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 43 | 74 | $5,180 | $2,365 | 45.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $4,396 | $2,056 | 46.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2021 | 24 | 24 | $2,424 | $992.68 | 41.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 14 | 14 | $1,764 | $817.04 | 46.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 12 | $1,512 | $714.92 | 47.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 143 | 146 | $49,056 | $24,210 | 49.4% |
About Dr. Ivan Alger, DO
Dr. Ivan Alger, DO is a Internal Medicine healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2014. The National Provider Identifier (NPI) number assigned to this provider is 1366861619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Alger, DO has received a total of $967.00 in payments from pharmaceutical and medical device companies, with $91.91 received in 2022. These payments were reported across 35 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($967.00).
As a Medicare-enrolled provider, Alger has provided services to 2,625 Medicare beneficiaries, totaling 4,046 services with total Medicare billing of $321,478. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Newport News, VA
- Active Since 04/15/2014
- Last Updated 01/23/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1366861619
Products in Payments
- ELIQUIS (Drug) $414.29
- EVZIO (Drug) $107.06
- INGREZZA (Drug) $91.91
- ENTRESTO (Drug) $90.16
- XARELTO (Drug) $63.12
- Corlanor (Drug) $50.48
- DIFICID (Drug) $33.83
- UTIBRON (Drug) $29.38
- FASENRA (Drug) $26.21
- Precision Flow (Device) $18.78
- LifeVest (Device) $16.67
- SMARTVEST (Device) $13.49
- TEFLARO (Drug) $11.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport News
Dr. Subramanian Malaisamy, Mbbs, Mrcp (Uk), MBBS, MRCP (UK)
Internal Medicine — Payments: $12,702
Internal Medicine $12,702
Dr. Tokunbo Matthews, M.d, M.D
Internal Medicine — Payments: $9,551
Internal Medicine $9,551
Agnieszka Petersen, Md, MD
Internal Medicine — Payments: $9,234
Internal Medicine $9,234
Dr. Masood Ahmed, Md, MD
Internal Medicine — Payments: $7,637
Internal Medicine $7,637
Dr. Robert Comer, M.d, M.D
Internal Medicine — Payments: $7,412
Internal Medicine $7,412
Thomas Harrington, M.d, M.D
Internal Medicine — Payments: $6,878
Internal Medicine $6,878